1 - 15 June 2018
These are links to news stories from the last two weeks that may be of interest to people in the UK. The link beneath each item will take you to the original story.
Please note that the MS Trust did not write the original items and does not endorse their content nor any claims made in them.
To keep up to date on all the latest news, views and research on multiple sclerosis, sign up for Open Door, our free newsletter or regular email alerts
School project explores MS
Tecfidera and Gilenya compared
Tecfidera (dimethyl fumarate) and Gilenya (fingolimod) were equally effective in people taking their first disease modifying drug (DMD) according to an Italian study. In people switching from an injectable DMD, Gilenya was a little bit better
Source: MS News Today
MS Trust link: MS Decisions - a guide to disease modifying drugs for relapsing remitting multiple sclerosis
Ocrevus delays progression
Ocrevus (ocrelizumab) delays getting to EDSS 7.0 (needing to use a wheelchair) by about seven years according to data to be presented at the European Academy of Neurology meeting. This figure is an extrapolation based on the reduced risk of progression seen in a 120 week trial.
Source: Roche press release
MS Trust link: Ocrevus (ocrelizumab)
Ocrevus in PPMS - new trial announced
The effect of Ocrevus (ocrelizumab) on upper limb function in people with primary progressive MS will be explored in a new trial due to start before the end of the year. More details, including where the trial will take place, have not yet been announced.
Source: News Medical
MS Trust link: Primary progressive MS
Obesity and smoking and risk of MS
Being overweight and being a smoker at the age of 20 makes someone more likely to get MS and to get to secondary progressive MS quicker according to a Swedish study of medical records. The faster time to SPMS didn't occur in people who were overweight but who didn't smoke
Source: MS News Today
MS Trust link: Living well with MS
Move it for MS Nick's story
7 Oct 2021 - 00:00
Nick, was diagnosed with relapsing remitting Multiple Sclerosis at the start of the first lockdown. In this story we talk to him about how he coped with his diagnosis and how running helps him with his MS.
David's diary - Inclusion and diversity, where are we now?
6 Oct 2021 - 00:00
Just over a year ago we published a diary entry about Inclusivity and Diversity at the MS Trust. In this piece we take a look at what's changed since then and what we still need to do.
Flu season 2021
4 Oct 2021 - 00:00
This year is likely to involve a bigger flu vaccination programme in the UK, including for people with multiple sclerosis (MS), due to the circulation of Covid-19 at the same time. Here we discuss who's eligible for a flu jab on the NHS and how to get one.
Sign up for updates from us
Keep up-to-date with the latest MS news, explore new research, read the stories of people living with MS, find out practical tips from MS experts, and discover exciting fundraising opportunities.